✦ LIBER ✦

P1150 BASELINE CHARACTERISTICS AND TREATMENT EFFICACY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2a AND RIBAVIRIN IN 253 HCV GENOTYPE 1 NONRESPONDER PATIENTS IN A REAL-WORLD SETTING

✍ Scribed by Hofmann, W.P.; Mauss, S.; Baumgarten, A.; Boeker, K.H.W.; Link, R.; Naumann, U.; Geyer, P.R.; Schuchmann, M.; Stoehr, A.; Loehr, H.; Schober, A.; Moog, G.; Holm, S.; Heyne, R.; Eisenbach, C.; Lutz, T.; Alshuth, U.; Hueppe, D.

Book ID: 122714046
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 60 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)61310-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

290 EARLY VIROLOGICAL RESPONSE PROFILES

290 EARLY VIROLOGICAL RESPONSE PROFILES WITH TELAPREVIR (T) IN COMBINATION WITH PEGINTERFERON-ALFA-2A (P) AND RIBAVIRIN (R) IN GENOTYPE 1 HCV TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS ARE SIMILAR

✍ F. Poordad; J.G. McHutchison; M.L. Shiffman; T. Berg; A.J. Muir; M.P. Manns; A.M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 188 KB

10 RESULTS OF A PROOF OF CONCEPT STUDY (

10 RESULTS OF A PROOF OF CONCEPT STUDY (C210) OF TELAPREVIR MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 4 HCV PATIENTS

✍ Y. Benhamou; J. Moussalli; V. Ratziu; P. Lebray; V. Gysen; K. de Backer; A. Ghys 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

805 WEEK 4 AND 12 EFFICACY OF TELAPREVIR

805 WEEK 4 AND 12 EFFICACY OF TELAPREVIR (TVR) IN COMBINATION WITH PEGINTERFERON alfa 2a/RIBAVIRIN (P/R) IN TREATMENT EXPERIENCED PATIENTS WITH GT-1 UNDER REAL LIFE CONDITIONS

✍ Christensen, S.; Mauss, S.; Eisenbach, C.; Jung, M.-C.; Roessle, M.; Emke, F.; P 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

1193 A DESCRIPTION OF VIROLOGIC ESCAPE I

1193 A DESCRIPTION OF VIROLOGIC ESCAPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH DACLATASVIR (BMS-790052) IN COMBINATION WITH RIBAVIRIN AND PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B

✍ McPhee, F.; Hernandez, D.; Yu, F.; Ueland, J.; Chayama, K.; Toyota, J.; Izumi, N 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

251 GENOTYPIC AND PHENOTYPIC CHARACTERIZ

251 GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF GENOTYPE 2/3 HCV VARIANTS IN PATIENTS TREATED WITH TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A/RIBAVIRIN IN STUDY C209

✍ S. De Meyer; G.R. Foster; A. Ghys; M. Beumont; B. Van Baelen; T.-I. Lin; G. Picc 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

871 REAL-WORLD EFFICACY AND SAFETY OF TE

871 REAL-WORLD EFFICACY AND SAFETY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY

✍ Mauss, S.; Boeker, K.H.W.; Eisenbach, C.; Moeller, B.; Moog, G.; Lutz, T.; Nauma 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 72 KB